机构:[1]Department of Echocardiography, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China医技科室超声心动科首都医科大学附属安贞医院
Marfan syndrome (MFS) is an autosomal dominant genetic disorder of the connective tissue, typically characteristic of cardiovascular manifestations, valve prolapse, left ventricle enlargement, and cardiac failure. Fibrillin-1 (FBN1) is the causative gene in the pathogenesis of MFS. Patients with different FBN1 mutations often present more considerable phenotypic variation. In the present study, three affected MFS pedigrees were collected for genetic analysis. Using next-generation sequencing (NGS) technologies, 3 novel frameshift pathogenic mutations which are cosegregated with affected subjects in 3 pedigrees were identified. These novel mutations provide important diagnostic and therapeutic insights for precision medicine in MFS, especially regarding the lethal cardiovascular events.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81501486, 81400846]; National Key R&D Program of China [2016YFC0903000]
第一作者机构:[1]Department of Echocardiography, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Echocardiography, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China
推荐引用方式(GB/T 7714):
Wang Yueli,Li Xiaoyan,Li Rongjuan,et al.Identification of Novel Causal FBN1 Mutations in Pedigrees of Marfan Syndrome[J].INTERNATIONAL JOURNAL OF GENOMICS.2018,2018:-.doi:10.1155/2018/1246516.
APA:
Wang, Yueli,Li, Xiaoyan,Li, Rongjuan,Yang, Ya&Du, Jie.(2018).Identification of Novel Causal FBN1 Mutations in Pedigrees of Marfan Syndrome.INTERNATIONAL JOURNAL OF GENOMICS,2018,
MLA:
Wang, Yueli,et al."Identification of Novel Causal FBN1 Mutations in Pedigrees of Marfan Syndrome".INTERNATIONAL JOURNAL OF GENOMICS 2018.(2018):-